🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a Phase 1, single-center, placebo-controlled, single-blind, f...
Status
Terminated
Location
Medpace Clinical Pharmacology Unit
Start Date
2009-06
Trial ID
NCT00927459
Treatments Being Tested
Cardiovascular disease(CVD) is the leading cause of morbidity and mortality...
Status
Unknown
Location
Academic Medical Center
Start Date
2011-09
Trial ID
NCT01601106
Treatments Being Tested
This multicentre, randomized controlled trial evaluates the effect and safe...
Status
Recruiting
Location
Guangdong Provincial Hospital of Chinese Medicine
Start Date
2026-01-15
Trial ID
NCT07337096
Treatments Being Tested
The safety and efficacy of pembrolizumab plus the investigator's choice of ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham-Medicine ( Site 0065)
Start Date
2021-06-18
Trial ID
NCT04895358
Treatments Being Tested
This is a study to determine the safety and tolerability of 28 days of dail...
Status
Completed
Location
Multiple Locations
Start Date
2008-06-24
Trial ID
NCT00775138
Treatments Being Tested
The removal of smooth, percutaneous pins (Perc Pins), which are used for fr...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT01542125
Treatments Being Tested
Background: \- Visceral leishmaniasis (VL) is an infection caused by paras...
Status
Withdrawn
Location
Kala-Azar Medical Research Center (KAMRC), Rambag Road
Start Date
TBD
Trial ID
NCT01437020
Treatments Being Tested
Exparel is a new local analgesic (numbing medication) that is intended to b...
Status
Completed
Location
University of Rochester Medical Center
Start Date
2013-03
Trial ID
NCT01826851
The purpose of this study is to determine if EL219 is safe and effective co...
Status
Recruiting
Location
U. of Alabama at Birmingham
Start Date
2026-02-13
Trial ID
NCT07215273
Treatments Being Tested
This is a phase II, multicentre, randomized, two-arm blinded study with an ...
Status
Completed
Location
DrugsNeglectedD Investigational Site
Start Date
2022-12-27
Trial ID
NCT05593666